Economic Burden of Psoriatic Arthritis

Author： Ackermann Christoph   Kavanaugh Arthur  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.26, Iss.2, 2008-01, pp. : 121-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Clinical Update and Global Economic Burden of Rheumatoid Arthritis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 2, 2018-02 ,pp. : 98-109

Bentham Science Publishers

Access to resources Recommend Favorite

Psoriatic arthritis

By Brockbank J.   Gladman D.D.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. : 1511-1522

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab: In Psoriatic Arthritis

By Simpson Dene   Scott Lesley J.  

Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. : 1487-1496

Adis International

Access to resources Recommend Favorite

Emerging drugs for psoriatic arthritis

By Olivieri Ignazio   D'Angelo Salvatore   Palazzi Carlo   Lubrano Ennio   Leccese Pietro  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. : 399-414

Informa Healthcare

Access to resources Recommend Favorite

Infliximab makes an impact in psoriatic arthritis

By  

Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite